Abstract
Pretransplant detection of KMT2Ar measurable residual disease ≥0.001% by quantitative polymerase chain reaction was associated with significantly inferior posttransplant survival (2-year relapse-free survival 17% vs 59%; P = .001) and increased 2-year cumulative incidence of relapse (75% vs 25%, P = .0004).
Subjects:
Myeloid Neoplasia
References
1.
Döhner
H
, Wei
AH
, Appelbaum
FR
, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
. Blood
. 2022
;140
(12
):1345
-1377
.2.
Hernandez-Sanchez
A
, Gonzalez
T
, Sobas
M
, et al. Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications—a HARMONY study
. Leukemia
. 2024
;38
(9
):1929
-1937
.3.
Menghrajani
K
, Gomez-Arteaga
A
, Madero-Marroquin
R
, et al. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-adverse-risk, and KMT2A-rearranged AML
. Blood Adv
. 2022
;6
(3
):828
-847
.4.
Scholl
C
, Breitinger
H
, Schlenk
RF
, et al. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia
. Genes Chromosomes Cancer
. 2003
;38
(3
):274
-280
.5.
Heuser
M
, Freeman
SD
, Ossenkoppele
GJ
, et al. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
. Blood
. 2021
;138
(26
):2753
-2767
.6.
Huang
S
, Yang
H
, Li
Y
, et al. Prognostic significance of mixed-lineage leukemia (MLL) gene detected by real-time fluorescence quantitative PCR assay in acute myeloid leukemia
. Med Sci Monit
. 2016
;22
:3009
-3017
.7.
Liu
J
, Wang
Y
, Xu
LP
, et al. Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia—rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation
. Biol Blood Marrow Transplant
. 2014
;20
(7
):929
-936
.8.
Ommen
HB
, Hokland
P
, Haferlach
T
, et al. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene
. Br J Haematol
. 2014
;165
(5
):618
-628
.9.
Meyer
C
, Larghero
P
, Almeida Lopes
B
, et al. The KMT2A recombinome of acute leukemias in 2023
. Leukemia
. 2023
;37
(5
):988
-1005
.10.
Meyer
C
, Burmeister
T
, Groger
D
, et al. The MLL recombinome of acute leukemias in 2017
. Leukemia
. 2018
;32
(2
):273
-284
.11.
Issa
GC
, Aldoss
I
, DiPersio
J
, et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
. Nature
. 2023
;615
(7954
):920
-924
.12.
Issa
GC
, Aldoss
I
, Thirman
MJ
, et al. Menin inhibition with revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101)
. J Clin Oncol
. 2024
:JCO2400826
.13.
Abildgaard
L
, Ommen
HB
, Lausen
B
, Hasle
H
, Nyvold
CG
. A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia
. Eur J Haematol
. 2013
;91
(5
):394
-398
.© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2024
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal